Medeon Biodesign Financials
| 6499 Stock | TWD 43.20 1.20 2.70% |
Medeon |
Understanding current and past Medeon Biodesign Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medeon Biodesign's financial statements are interrelated, with each one affecting the others. For example, an increase in Medeon Biodesign's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Medeon Biodesign's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medeon Biodesign. Check Medeon Biodesign's Beneish M Score to see the likelihood of Medeon Biodesign's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0006499007 |
| Business Address | 116, HouGang Street, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.medeonbio.com |
| Phone | 886 2 2881 6686 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Medeon Biodesign without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medeon Stock, because this is throwing your money away. Analyzing the key information contained in Medeon Biodesign's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Medeon Biodesign Key Financial Ratios
There are many critical financial ratios that Medeon Biodesign's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medeon Biodesign reports annually and quarterly.Medeon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medeon Biodesign's current stock value. Our valuation model uses many indicators to compare Medeon Biodesign value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medeon Biodesign competition to find correlations between indicators driving Medeon Biodesign's intrinsic value. More Info.Medeon Biodesign is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medeon Biodesign's earnings, one of the primary drivers of an investment's value.Medeon Biodesign Systematic Risk
Medeon Biodesign's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medeon Biodesign volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Medeon Biodesign correlated with the market. If Beta is less than 0 Medeon Biodesign generally moves in the opposite direction as compared to the market. If Medeon Biodesign Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medeon Biodesign is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medeon Biodesign is generally in the same direction as the market. If Beta > 1 Medeon Biodesign moves generally in the same direction as, but more than the movement of the benchmark.
Medeon Biodesign November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medeon Biodesign help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medeon Biodesign. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medeon Biodesign based on widely used predictive technical indicators. In general, we focus on analyzing Medeon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medeon Biodesign's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 12.48 | |||
| Value At Risk | (1.93) | |||
| Potential Upside | 2.55 |
Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.